Best Peptides for Longevity: Stack and Doses 2026
NAD+ + Epitalon + GHK-Cu + Tesamorelin: four peptides targeting the four pillars of biological aging — mitochondrial function, telomere maintenance, systemic repair, and body composition.
Why These Four Peptides
NAD+ — Mitochondrial Fuel
Nicotinamide adenine dinucleotide. Central cofactor for mitochondrial ATP production and sirtuin activation. Declines with age. Restoring it has direct effects on cellular energy, DNA repair, and inflammation regulation.
Best for: Energy, mitochondrial function, sirtuin support
Route: IV infusion or subcutaneous
Epitalon — Telomere & Pineal Support
A 4-amino-acid peptide derived from pineal gland research. Activates telomerase in some cell lines, supports pineal melatonin signaling, and regulates the circadian-aging axis. Short cycles, large between-cycle gaps.
Best for: Telomere maintenance, melatonin axis, sleep architecture
Route: Subcutaneous, 10–20 day cycles
GHK-Cu — Systemic Repair
Copper tripeptide. Modulates inflammatory cytokines, drives connective tissue regeneration, and has gene expression effects on hundreds of repair-related pathways. The most visible early marker is skin quality, but systemic effects are the long-term goal.
Best for: Skin, connective tissue, inflammation
Route: Subcutaneous, daily
Tesamorelin — Body Composition
GHRH analog. Triggers a natural GH pulse, which over weeks reduces visceral adipose tissue (the most damaging fat depot for metabolic and inflammatory aging) while supporting muscle retention. Body composition is a longevity proxy.
Best for: Visceral fat, body composition, IGF-1 support
Route: Subcutaneous, at bedtime
Complementary Synergy: NAD+ fuels the energy and DNA repair machinery. Epitalon supports the telomere and circadian layer. GHK-Cu drives systemic repair. Tesamorelin shifts body composition into a more aging-resistant profile. Four mechanisms, one direction of travel.
Dosing Protocol
| Peptide | Dose | Frequency | Timing | Duration |
|---|---|---|---|---|
| NAD+ | 100–250mg | 2–3x weekly | IV or SC, morning | 8–12 weeks, then maintain |
| Epitalon | 5–10mg | Daily | Evening, SC | 10–20 days, then 6-month gap |
| GHK-Cu | 1–2mg | Daily | Evening, SC | 4–8 weeks per cycle |
| Tesamorelin | 1–2mg | Daily | At bedtime, SC | 8 weeks on, 4 off |
This is a 4-component stack. Most users start with 2 components and add the others once baseline labs and tolerance are established. Running all 4 from day one is not recommended.
Stack Variations by Goal
First-time longevity protocol
NAD+ + GHK-Cu only
Start with the two most established components. Run for 8 weeks, re-test, then layer in Epitalon and Tesamorelin.
Body composition focus
Tesamorelin + GHK-Cu + NAD+
Skip Epitalon. The first three components drive the most visible body composition and recovery changes.
Sleep + circadian repair
Epitalon + NAD+ + Tesamorelin
Drop GHK-Cu temporarily. Focus on the circadian axis. Pairs well with the Sleep Stack protocol.
Post-illness recovery (40+)
NAD+ + GHK-Cu (full stack later)
NAD+ rebuilds mitochondrial reserves. GHK-Cu modulates lingering inflammation. Add Tesamorelin once baseline strength returns.
Aesthetic longevity
GHK-Cu + Tesamorelin + NAD+
GHK-Cu skin effects + Tesamorelin body composition + NAD+ energy. The visible longevity stack.
Cellular aging focus (50+)
Full stack
All four components. Most aggressive protocol. Requires baseline labs and quarterly monitoring.
Longevity Response Timeline
NAD+ effects (energy, clarity) usually emerge within the first 3–7 days of dosing. Epitalon and GHK-Cu effects are slower. Tesamorelin begins its body composition work.
GHK-Cu starts to show on skin quality (the most visible early marker). Tesamorelin visceral fat reduction begins to be measurable. Sleep often improves indirectly.
Mid-cycle. IGF-1 and inflammation markers should be re-tested. NAD+ users often shift to a maintenance frequency by this point.
Plateau and re-evaluate. Continue the components that produced measurable change. Drop the components that did not.
Critical Points
Cancer & Growth Caution:Tesamorelin raises IGF-1, GHK-Cu is pro-angiogenic, and Epitalon's telomerase effects are not fully characterized. Those with active cancer or significant cancer history should consult an oncologist before running this stack. NAD+ alone is the lowest-risk subset for cancer-cautious individuals.